https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-152009-10-01 00:00:002019-02-15 08:49:26Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Hum. Gene Ther. 2009 Oct;20(10):1106-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Hum. Gene Ther. 2009 Oct;20(10):1106-182009-10-01 00:00:002019-02-15 08:44:11Dendritic cell-based cancer gene therapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-10-01 / Breast 2009 Oct;18 Suppl 3:S51-4
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-10-01 / Breast 2009 Oct;18 Suppl 3:S51-42009-10-01 00:00:002019-02-15 08:50:12Immunizing against breast cancer: a new swing for an old sword
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-76
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-762009-09-29 00:00:002019-02-15 08:36:11Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-22 / Mol. Ther. 2009 Dec;17(12):2049-57
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-22 / Mol. Ther. 2009 Dec;17(12):2049-572009-09-22 00:00:002019-02-15 08:48:18Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-15 / Exp. Dermatol. 2010 Feb;19(2):108-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-15 / Exp. Dermatol. 2010 Feb;19(2):108-162009-09-15 00:00:002019-02-15 08:48:17Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-08 / Mol. Ther. 2010 Feb;18(2):264-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-08 / Mol. Ther. 2010 Feb;18(2):264-742009-09-08 00:00:002019-02-15 08:44:16Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-01 / Prostate 2009 Sep;69(12):1343-52
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-01 / Prostate 2009 Sep;69(12):1343-522009-09-01 00:00:002019-02-15 08:48:19Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-01 / Ann. N. Y. Acad. Sci. 2009 Sep;1174:88-98
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-01 / Ann. N. Y. Acad. Sci. 2009 Sep;1174:88-982009-09-01 00:00:002019-02-15 08:44:14Harnessing dendritic cells to generate cancer vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-09-01 / Int. J. Oncol. 2009 Sep;35(3):569-81
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-09-01 / Int. J. Oncol. 2009 Sep;35(3):569-812009-09-01 00:00:002019-02-15 08:48:08Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer
